Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | SLC22A12 | Q96S37 | 13/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.40 |
| ▸ | SLC22A8 | Q8TCC7 | 2/20 | 0.40 |
| ▸ | SLC22A11 | Q9NSA0 | 2/20 | 0.40 |
| ▸ | MMP7 | P09237 | 1/20 | 0.40 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29449482 | 1.00 | MEN1 (0.50) | MEN1KMT2ASLC22A12RXFP1HSD11B1 | |
| SCHEMBL15000825 | 0.91 | MEN1 (0.43) | MEN1KMT2ASLC22A12RXFP1HSD11B1 | |
| SCHEMBL27448640 | 0.87 | MEN1 (0.43) | MEN1KMT2ASLC22A12RXFP1HSD11B1 | |
| SCHEMBL8854709 | 0.87 | MEN1 (0.43) | MEN1KMT2ASLC22A12RXFP1HSD11B1 | |
| SCHEMBL27466909 | 0.87 | MEN1 (0.43) | MEN1KMT2ASLC22A12RXFP1HSD11B1 | |
| SCHEMBL8409303 | 0.86 | MEN1 (0.47) | MEN1KMT2ASLC22A12RXFP1HSD11B1 | |
| SCHEMBL8854529 | 0.85 | MEN1 (0.41) | MEN1KMT2ASLC22A12RXFP1HSD11B1 | |
| SCHEMBL27532789 | 0.82 | MEN1 (0.44) | MEN1KMT2ASLC22A12RXFP1HSD11B1 | |
| SCHEMBL8762711 | 0.80 | MEN1 (0.43) | MEN1KMT2ASLC22A12RXFP1HSD11B1 | |
| SCHEMBL8729832 | 0.80 | MEN1 (0.43) | MEN1KMT2ASLC22A12RXFP1HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024101452-A1 | ELECTROLYTIC SOLUTION FOR NON-AQUEOUS SODIUM ION BATTERIES, NON-AQUEOUS SODIUM ION BATTERY, AND METHOD FOR PRODUCING NON-AQUEOUS SODIUM ION BATTERY | セントラル硝子株式会社 | 2024-05-16 | — | — | WO | disclosed |
| EP-3276735-B1 | NONAQUEOUS ELECTROLYTE FOR SODIUM SECONDARY BATTERY AND SODIUM SECONDARY BATTERY | SUMITOMO CHEMICAL CO (JP) | 2023-07-12 | — | — | EP | disclosed |
| US-20180123170-A1 | NONAQUEOUS ELECTROLYTE FOR SODIUM SECONDARY BATTERY AND SODIUM SECONDARY BATTERY | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-03 | — | — | US | disclosed |
| EP-3276735-A1 | NONAQUEOUS ELECTROLYTE FOR SODIUM SECONDARY CELL, AND SODIUM SECONDARY CELL | Sumitomo Chemical Company, Ltd. (JP) | 2018-01-31 | — | — | EP | disclosed |
| US-9882244-B2 | Rechargeable lithium ion battery | SAMSUNG SDI CO., LTD. (KR) | 2018-01-30 | — | — | US | disclosed |
| US-9837686-B2 | — | — | 2017-12-05 | — | — | US | disclosed |
| EP-2821395-B1 | Novel disulfonic acid ester as an additive for an electrolyte for a lithium secondary battery | WAKO PURE CHEM IND LTD (JP) | 2017-06-21 | — | — | EP | disclosed |
| US-9190695-B2 | Nonaqueous electrolyte solution, method for producing same, and nonaqueous electrolyte battery using the electrolyte solution | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2015-11-17 | — | — | US | disclosed |
| US-20150244028-A1 | NONAQUEOUS SECONDARY CELL, AND FIRE-RETARDANT AGENT AND ADDITIVE FOR NONAQUEOUS SECONDARY CELL | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2015-08-27 | — | — | US | disclosed |
| US-20150125742-A1 | RECHARGEABLE LITHIUM ION BATTERY | SAMSUNG SDI CO., LTD. (KR) | 2015-05-07 | — | — | US | disclosed |
| EP-2602855-B1 | NONAQUEOUS ELECTROLYTE SOLUTION, METHOD FOR PRODUCING SAME, AND NONAQUEOUS ELECTROLYTE BATTERY USING THE ELECTROLYTE SOLUTION | WAKO PURE CHEM IND LTD (JP) | 2015-02-18 | — | — | EP | disclosed |
| EP-2821395-A2 | Novel disulfonic acid ester as an additive for an electrolyte for a lithium secondary battery | Wako Pure Chemical Industries, Ltd. (JP) | 2015-01-07 | — | — | EP | disclosed |
| US-8716513-B2 | Process for production of bis-quaternary ammonium salt, and novel intermediate | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2014-05-06 | — | — | US | disclosed |
| EP-2602855-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, METHOD FOR PRODUCING SAME, AND NONAQUEOUS ELECTROLYTE BATTERY USING THE ELECTROLYTE SOLUTION | Wako Pure Chemical Industries, Ltd. (JP) | 2013-06-12 | — | — | EP | disclosed |
| US-20130143129-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, METHOD FOR PRODUCING SAME, AND NONAQUEOUS ELECTROLYTE BATTERY USING THE ELECTROLYTE SOLUTION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-06-06 | — | — | US | disclosed |
| EP-2463266-A1 | PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE | Wako Pure Chemical Industries, Ltd. (JP) | 2012-06-13 | — | — | EP | disclosed |
| US-20120130107-A1 | PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120130107-A1 | PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE | ASS1, C1S, FHIT | MEN1 786/4885KMT2A 2283/4885SLC22A12 1347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.